Previous 10 | Next 10 |
Becton, Dickinson press release ( NYSE: BDX ): Q1 Non-GAAP EPS of $2.98 beats by $0.30 . Revenue of $4.6B (-2.5% Y/Y) beats by $10M . Company raises full-year revenue and adjusted EPS guidance: The company now expects fiscal year 2023 revenues to be in the range of...
BD Reports First Quarter Fiscal 2023 Financial Results PR Newswire Execution of BD 2025 Strategy Delivering Consistent and Durable Performance Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis Revenue from bas...
Becton, Dickinson ( NYSE: BDX ) is scheduled to announce Q1 earnings results on Thursday, February 2nd, before market open. The consensus EPS Estimate is $2.68 (-26.4% Y/Y) and the consensus Revenue Estimate is $4.59B (-8.2% Y/Y). Over the last 2 years, BDX has beaten EPS es...
BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year PR Newswire Company's Ongoing Commitment to Advance Workplace Equality Shows Progress in Female Leadership and Talent Pipeline FRANKLIN LAKES, N.J. , Jan. 31, 2023 /PRNewswire/ -- BD...
Summary Yacktman's 13F equity portfolio value increased from $9.17B to $10.04B this quarter. Yacktman Asset Management increased Charles Schwab while decreasing PepsiCo, Sysco, and Weatherford International. Yacktman’s largest five stakes are at ~26% of the portfolio. ...
Summary ResMed continues to be a leading company in the industry, with multiple growth drivers ahead of its 2025 goals. But the outlook for ResMed doesn't look good, with YoY figures slowing and dividend payments possibly being interrupted. This has called its high valuation multipl...
Summary Today, VATE costs under $3 but is a bargain beneath $4. Their infrastructure business alone is worth $1. Life Sciences offers $15-$20 of embedded optionality. It's rare to uncover a single investment in the new economy that's best-in-class. To find a co...
BD Publishes 2022 Cybersecurity Annual Report PR Newswire Highlights Critical Importance of Transparency and Collaboration FRANKLIN LAKES, N.J. , Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical te...
Becton, Dickinson ( NYSE: BDX ) declares $0.91/share quarterly dividend , in line with previous. Forward yield 1.48% Payable March 31; for shareholders of record March 10; ex-div March 9. See BDX Dividend Scorecard, Yield Chart, & Dividend Growth. For fur...
Summary The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles. To understand where opportunity may lie, I ranked the group according to various financial metrics. Read on to se...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...